Adipogen International
Adipogen International (Adipogen Life Sciences) is a privately-held Swiss specialty life sciences reagent company that develops and distributes antibodies, recombinant proteins, ELISA kits, and biochemicals to academic researchers and pharmaceutical/biotech firms worldwide via direct regional e-commerce and a global distributor network.
- Company typePrivate
- Founded2011
- HeadquartersLiestal, Switzerland
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Adipogen International does
Adipogen International (legal entity: Adipogen Life Sciences) is a privately-held, Switzerland-based specialty life sciences reagent company founded in 2011 and operating from Liestal with 11–50 employees. The company develops and distributes monoclonal, polyclonal, and recombinant antibodies (including non-animal-source recombinant antibodies), recombinant proteins, ELISA kits, assay sets, biochemicals, dyes, and probes used in academic and pharmaceutical research. Its proprietary platforms include InVivoKines™ (in vivo functional grade antibodies) and B-Xpander™ (antibody expansion technology), and it serves a portfolio of more than ten distributed partner brands including Ancell, BellBrook, Bertin Bioreagent, BioViotica, Chemodex, Chimerigen, Innaxon, JaICA, RevMAb, South Bay Bio, and SYNkinase. The catalog is organized both by product type and by research field (inflammasomes, immuno-oncology, neuroscience, metabolism, apoptosis, cancer, COVID-19, immunometabolism, TNF superfamily, ubiquitin/proteasome, and others).
Adipogen sells primarily to two customer segments: academic and government research institutions (universities, research institutes, medical centers) and pharmaceutical/biotechnology companies engaged in drug discovery and preclinical research. Its go-to-market is digital-first — direct regional e-commerce storefronts in Switzerland, the UK, France, Germany, Austria, Italy, South Korea, and the United States — supplemented by an authorized international distributor network spanning Europe, the Americas, the Middle East, Africa, Australia, and Asia. Demand-generation relies on the corporate website, an E-News newsletter, LinkedIn, and participation in scientific conferences rather than a traditional field salesforce. All products are labeled for Research Use Only (RUO), and pricing is not publicly disclosed.
The business model is a hybrid of specialty distribution and proprietary brand development: revenue is generated by selling third-party partner brands alongside higher-margin AdipoGen-labeled reagents, with no subscription, licensing, or services component disclosed. The company is independent and privately-held with no disclosed venture capital, private equity backing, parent company, subsidiaries, M&A history, or leadership changes on record. No revenue figures, certifications, patents, awards, or AI/ML capabilities are disclosed in available sources.
Adipogen International firmographics
Firmographics- Name
- Adipogen International
- Legal name
- Adipogen Life Sciences
- Website
- https://adipogen.com
- Company type
- Private
- Founded year
- 2011
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Adipogen International (Adipogen Life Sciences) is a privately-held Swiss specialty life sciences reagent company that develops and distributes antibodies, recombinant proteins, ELISA kits, and biochemicals to academic researchers and pharmaceutical/biotech firms worldwide via direct regional e-commerce and a global distributor network.
- Ownership category
- akta.pro rank
Where Adipogen International is headquartered
LocationHeadquarters
- HQ city
- Liestal
- HQ country
- Switzerland
- HQ region
- Europe
Markets served
Adipogen International business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales
Distribution channels2 records
Marketing channels4 records
Adipogen International product offering
Product offeringCore offering
Adipogen International develops, manufactures, and distributes life sciences research reagents used by academic and pharmaceutical researchers. Its product range spans monoclonal, polyclonal, and recombinant (non-animal-source) antibodies, recombinant proteins, validated ELISA kits, assay sets, biochemical inhibitors, fluorescent dyes and probes, and proprietary in vivo functional grade antibodies. The company sells directly through country-specific online stores and via authorized distributors, with all products labeled Research Use Only (RUO).
Product overview
Adipogen Life Sciences is a research reagent distributor specializing in antibodies, proteins, assays, and biochemicals for life sciences research. The company operates as a portfolio of branded product lines and distributed partner brands. Core products include monoclonal, polyclonal, and recombinant antibodies (including non-animal source antibodies and Multiclonals), recombinant proteins (with enhanced activity and stability), Gold Standard ELISA Kits, and assay sets. Their biochemical portfolio includes specialized inhibitors (Bafilomycin A, Salinosporamide A, DYRK Inhibitors, Manumycin A), receptor agonists (GLP-1 & GIP, Resiniferatoxin), and research reagents (alphaGalCer, Latrunculin A & B, PMA, Suramin). Proprietary brands include InVivoKines™ (in vivo functional antibodies), B-Xpander™ (antibody expansion technology), and TRIAL Size Antibodies. Products support research across multiple fields including Apoptosis, Cancer, COVID-19, Cytokines & Interleukins, Immunology, Immunometabolism, Immuno-Oncology, Inflammasomes, Inflammation, Innate Immunity, Metabolism, Neuroscience, Obesity, Oxidative Stress, TNF Superfamily, and Ubiquitin & Proteasome. The company distributes products from partner brands including Ancell, BellBrook, Bertin Bioreagent, BioViotica, Chemodex, Chimerigen, Innaxon, JaICA, RevMAb, South Bay Bio, and SYNkinase. All products are intended for Research Use Only (RUO).
Differentiator
Problem solved
Functional benefit
Brands
- AdipoGen Life Sciences: Primary brand for life sciences research reagents including antibodies, proteins, assays, and biochemicals
Products and services
- Monoclonal Antibodies Monoclonal antibodies for research applications including Western Blot, immunoprecipitation, IHC/ICC/IF, flow cytometry, and ELISA.
- Polyclonal Antibodies Polyclonal antibodies supporting a range of research experimental techniques.
- Recombinant Antibodies (non-animal source) Recombinant antibodies produced without animal use, including Multiclonal recombinant secondary antibodies, for research applications.
- Recombinant Proteins Recombinant proteins including multimeric proteins and proteins with enhanced activity and stability for research applications.
- ELISA Kits Validated Gold Standard ELISA kits for quantitative detection of biomarkers including Erythroferrone and GDF15 assays.
- Assay Sets Ready-to-use assay sets for various research applications.
- Biochemicals Biochemical reagents including antibiotics, natural products, and small molecules for life sciences research.
- Dyes & Probes Fluorescent dyes and probes for research applications.
- Other Reagents Additional research reagents supporting various experimental needs.
- InVivoKines Proprietary line of in vivo functional grade antibodies for preclinical research applications.
- TRIAL Size Antibodies Trial-sized antibody products available for initial research evaluation.
Companies that use Adipogen International
Customer profileSegments2 records
Ideal customer profiles2 records
Adipogen International technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature6 records
Adipogen International partnerships and signals
Strategic signalRecent moves5 records
Expansion highlights5 records
Adipogen International competitors and assessment
Company assessmentDirect peers
- Cell Signaling Technology: US-based specialty antibody and reagent manufacturer focused on signal transduction, apoptosis, and immunology research. Directly comparable to Adipogen in product categories (antibodies, ELISA kits) and customer base (academic and pharma researchers), though at significantly larger scale.
- Abcam: Cambridge, UK-based specialist in research-grade antibodies with global e-commerce distribution. Closely comparable to Adipogen in business model (specialty antibody catalog, web-first sales, life-sciences research customer base).
- Cayman Chemical: US-based manufacturer and distributor of biochemicals, inhibitors, ELISA kits, and assay reagents for life-sciences research. Closely comparable to Adipogen in its biochemical and assay kit focus, particularly around eicosanoid and natural product inhibitors.
- Santa Cruz Biotechnology: US-based supplier of research antibodies, biochemicals, and lab reagents to academic and pharma customers. Overlaps directly with Adipogen's antibody and biochemical catalog breadth and customer profile.
- MBL International: Japanese-headquartered reagent manufacturer with global distribution of antibodies, ELISA kits, and assay kits. Similar scale, geographic footprint, and product mix to Adipogen, with comparable focus on immunology and apoptosis research.
- StressMarq Biosciences: Canada-based reagent supplier specializing in antibodies, proteins, and ELISA kits for stress, neuroscience, and cell-death research. Similar size and product specialization to Adipogen, particularly around inflammasome and cell-death pathways.
Broad incumbents
- Bio-Techne: Parent of R&D Systems, Novus Biologicals, Tocris, and ProteinSimple, Bio-Techne is a major life-sciences reagent supplier spanning antibodies, proteins, ELISA kits, and small molecules — directly overlapping Adipogen's catalog across most research areas.
- Thermo Fisher Scientific (Life Sciences / Invitrogen): Dominant life-sciences tool incumbent offering antibodies (Invitrogen), proteins, ELISA kits, and biochemicals across all of Adipogen's research areas. Represents the upper-bound scale competitor against which Adipogen must differentiate through specialization.
- Merck MilliporeSigma (Life Science): Broad-line life-science reagent and biochemical supplier offering antibodies, proteins, ELISA kits, and small molecules globally. Comparable in product breadth to Adipogen, though at much larger scale and with deeper catalog depth in commodity reagents.
Emerging players
- Bertin Bioreagent: France-based developer of immunoassay kits, antibodies, and reagents for inflammation and immunology research. Already a partner brand distributed by Adipogen, demonstrating direct catalog overlap and a closer commercial relationship than a pure competitor.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks5 records
Key highlights6 records
Customer concentration
Adipogen International social profiles
Digital presenceAdipogen International financial estimates
Financial estimateRevenue estimate
Valuation estimate
Adipogen International leadership team
Management profileNumber of profiles
Adipogen International funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Adipogen International M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Adipogen International
What does Adipogen International do?
Adipogen International develops, manufactures, and distributes life sciences research reagents used by academic and pharmaceutical researchers. Its product range spans monoclonal, polyclonal, and recombinant (non-animal-source) antibodies, recombinant proteins, validated ELISA kits, assay sets, biochemical inhibitors, fluorescent dyes and probes, and proprietary in vivo functional grade antibodies. The company sells directly through country-specific online stores and via authorized distributors, with all products labeled Research Use Only (RUO).
Is Adipogen International a public or private company?
Adipogen International is a private company. It is classified as unknown and is currently operating.
When was Adipogen International founded?
Adipogen International was founded in 2011. It employs 11 to 50 people.
Where is Adipogen International based?
Adipogen International is headquartered in Liestal, Switzerland, in the Europe region.
Who are Adipogen International's main competitors?
Direct peers on record are Cell Signaling Technology, Abcam, Cayman Chemical, Santa Cruz Biotechnology, MBL International and StressMarq Biosciences. Broad incumbents are Bio-Techne, Thermo Fisher Scientific (Life Sciences / Invitrogen) and Merck MilliporeSigma (Life Science). Bertin Bioreagent is listed as an emerging player.
Does Adipogen International have an API?
No public API is recorded for Adipogen International.